P140. Professional Practice (1 s.h.) F.

An introductory course which begins the process of professionalization. Information discussed will assist students in understanding their legal, ethical and professional responsibilities. Pharmaceutical care issues will be discussed.

P146. Drug Information (1 s.h.) S.

This course is designed to familiarize the student with available sources for locating drug information and to help students develop skills needed to effectively utilize these sources.

P233. Pathophysiology/Therapeutics Cardiopulmonary (4 s.h.) F.

The pathophysiology and clinical manifestations of selected cardiac and pulmonary disease will be presented as a basis for the discussion of rational drug therapy for diseases affecting these organ systems. Monitoring therapeutic outcomes is emphasized.

P237. Pathophysiology/Therapeutics -Renal and Metaboloic Disorders (3 s.h.) S.

The pathophysiology and clinical manifestations of selected renal, metabolic and endocrine disorders will be presented as a basis for the discussion of rational drug therapy for these disorders. The effect of renal disease on drug disposition will be emphasized. Monitoring therapeutic outcomes is also emphasized.

P239. Introduction to the Provision of Pharmaceutical Care/Recitation (2 s.h.) F.

The didactic component of this course is designed to prepare the student for the subsequent Pathophysiology/Therapeutics courses that focus on the treatment of specific disease states. Concepts to be covered include: 1) developing a pharmaceutical care plan; 2) analysis of laboratory tests and 3) principles of adverse drug reactions and drug interactions. Students will work in teams to develop pharmaceutical care plans which are presented and discussed in small group recitations.

P246. Pharmaceutical Care Recitation II (1 s.h.) S.

Students work in teams applying their knowledge to develop pharmaceutical care plans for patients with disease states being covered concurrently in the Pathophysiology/Therapeutics Courses. Care plans are presented and discussed in small group recitations.

P248. Communication/ Skills (1 s.h.) F.

This course is designed to provide students with a background in verbal communication skills. A variety of experiences will be provided to help students fine tune their ability to communicate orally.

P254. Biostatistics/Medical literature Evaluation (2 s.h.) S.

Students will critically analyze and evaluate biomedical literature. The application of common statistical methods in literature evaluation will be emphasized.

P260. Contemporary Pharmacy Practice (2 s.h.) S.

This laboratory course is divided into segments providing students with experience using a pharmacy computer system, performing physical assessment, counseling patients in simulated situations and preparing sterile products.

P270. Pathophysiology/Therapeutics - Gastroenterology/Nutrition (2 s.h.) S.

The pathophysiology and clinical manifestations of selected gastrointestinal and hepatic disorders will be presented as a basis for the discussion of rational drug therapy for diseases affecting these organ systems. The effect of liver disease on drug disposition will be emphasized. Principles of enteral and parenteral nutrition will be covered. Monitoring therapeutic outcomes is also emphasized.

P313. Therapeutic Drug Monitoring : The Clinical Application of Pharmacokinetic and Pharmacodynamic Principles (3 s.h.) F.

The course sequence is designed to provide the student with exposure to the application of pharmacokinetic and pharmacodynamic principles as they apply to specific drug classes in various clinical situations. Emphasis will be placed on the use of mathematical principles to predict drug disposition in individual patients. In addition, effect:time and concentration:effect relationships will be explored and application to clinical situations emphasized.

P321. Pathophysiology/Therapeutics -Neurology/Psychiatry (2 s.h.) F.

The pathophysiology and clinical manifestations of selected neurologic, and psychiatric diseases will be presented as a basis for the discussion of rational drug therapy for these conditions. Monitoring therapeutic outcomes is emphasized.

P323. Pathophysiology/Therapeutics -Hematology/Oncology (2 s.h.) F.

The pathophysiology and clinical manifestations of selected hematologic, and oncologic disorders will be presented as a basis for the discussion of rational drug therapy for these diseases. The rational use of supportive therapy in the management of patients receiving chemotherapy will be covered. Monitoring therapeutic outcomes is emphasized.

P332. Immunology/Dermatology/Ophthalmology (2 s.h.) S.

The pathophysiology and clinical manifestations of selected diseases affecting the immune system, skin and eyes will be presented as a basis for the discussion of rational drug therapy for conditions affecting these organ systems. Monitoring therapeutic outcomes is emphasized.

P334. Cardiopulmonary II (2 s.h.) S.

The pathophysiology and clinical manifestations of complex diseases affecting the cardiac, pulmonary and vascular organ systems will be presented as a basis for the discussion of rational drug therapy for these conditions. Monitoring therapeutic outcomes is emphasized.

P338. Renal/Metabolic Disorders II (2 s.h.) S.

The pathophysiology and clinical manifestations of complex renal, metabolic and endocrine disorders will be presented as a basis for the discussion of rational drug therapy for these diseases. Principles of fluid and electrolyte therapy will be covered. Monitoring therapeutic outcomes is emphasized.

P347. Pharmaceutical Care Recitation III (1 s.h.) F.

Students work in teams applying their knowledge to develop pharmaceutical care plans for patients with disease states being covered concurrently in the Pathophysiology/Therapeutics Courses. Care plans are presented and discussed in small group recitations.

P348. Pharmaceutical Care Recitation IV/Multisystem Disorders (1 s.h.) S.

Students will utilize the knowledge and skills gained in the previous Pathophysiology/Therapeutics courses and recitations to independently solve drug related problems in patients with diseases affecting multiple organ systems.

P371. Drugs, Devices, and Consumers (3 s.h.) S.

Drugs of inorganic origin, over-the-counter drugs, and devices based on medical use or therapy. The interaction and relationship of the pharmacist with patient-consumer.

P622. Clerkship/Inpatient Clinical (5 s.h.) F S.

Students will apply their knowledge and skills to actively participate in the care of the hospitalized patient. Students will learn to take responsibility for appropriate drug use, and for identifying and solving drug-related problems in order to improve patient care and health outcomes. Written documentation of student interventions and effective verbal communication with patients and members of the healthcare team will be emphasized.

P624. Clerkship/Ambulatory Care Clinical (5 s.h.) F S.

Students will apply their knowledge and skills to actively participate in the care of patients in an ambulatory care setting. Students will learn to take responsibility for appropriate drug use, and for identifying and solving drug-related problems in order to improve patient care and health outcomes. Written documentation of interventions and effective verbal communication with patients and members of the healthcare team will be emphasized.

P721. Clerkship/Community Pharmacy (5 s.h.) F S.

Students will gain experience performing the traditional distributive and compounding responsibilities of the pharmacist while providing pharmaceutical care to patients in a community or chain pharmacy under the supervision of a pharmacist.

P723. Clerkship/Institutional Pharmacy (5 s.h.) F S.

Students will gain experience performing the traditional distributive, and compounding responsibilities of a hospital pharmacist while providing pharmaceutical care to hospitalized patients under the supervision of a pharmacist.

P725 and P726. Clerkship/Elective (5 s.h.) F S.

Students complete two elective clerkships to gain experience in specific practice areas of interest. Rotations in clinical specialties, pharmaceutical industry, managed care, long term care, home health care, clinical research, pharmacy management, teaching, the Public Health Service, and professional organizations are examples of elective clerkship rotations.